A Phase I Study of CS5007 in Participants With Advanced Solid Tumors

Clinical trial NCT07622524 · RECRUITING

Trial details

NCT number: NCT07622524
Sponsor: CStone Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-07-16
Primary completion: 2028-01-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.